These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
114 related articles for article (PubMed ID: 3338184)
1. Purification of anti-apolipoprotein CIII antibodies by exploiting their affinity for apolipoprotein CIII linked to polyacrylamide gel after isoelectric focusing. Alsayed N; Drüeke TB; Lacour B Clin Chem; 1988 Jan; 34(1):49-52. PubMed ID: 3338184 [TBL] [Abstract][Full Text] [Related]
2. A simple micromethod for rapid assessment of the distribution of apolipoprotein C isoforms in very-low-density lipoprotein. Harake B; Caines PS; Thibert RJ; Cheung RM Clin Biochem; 1991 Jun; 24(3):255-60. PubMed ID: 1873909 [TBL] [Abstract][Full Text] [Related]
3. Modulation of lipoprotein B binding to the LDL receptor by exogenous lipids and apolipoproteins CI, CII, CIII, and E. Clavey V; Lestavel-Delattre S; Copin C; Bard JM; Fruchart JC Arterioscler Thromb Vasc Biol; 1995 Jul; 15(7):963-71. PubMed ID: 7600129 [TBL] [Abstract][Full Text] [Related]
5. Apolipoproteins as the basis for heterogeneity in high-density lipoprotein2 and high-density lipoprotein3. Studies by isoelectric focusing on agarose films. Marcel YL; Weech PK; Nguyen TD; Milne RW; McConathy WJ Eur J Biochem; 1984 Sep; 143(3):467-76. PubMed ID: 6479161 [TBL] [Abstract][Full Text] [Related]
6. Demonstration of an abnormality of C apoprotein of very low density lipoprotein in patients with gout. Macfarlane DG; Midwinter CA; Dieppe PA; Bolton CH; Hartog M Ann Rheum Dis; 1985 Jun; 44(6):390-4. PubMed ID: 4015201 [TBL] [Abstract][Full Text] [Related]
7. Apolipoprotein-CIII Naber A; Demus D; Slieker R; Nicolardi S; Beulens JWJ; Elders PJM; Lieverse AG; Sijbrands EJG; 't Hart LM; Wuhrer M; van Hoek M Int J Mol Sci; 2023 Oct; 24(19):. PubMed ID: 37834292 [TBL] [Abstract][Full Text] [Related]
8. Apolipoprotein E phenotyping from plasma by isoelectric focusing and immunoblotting. Eto M; Watanabe K; Moriyama T; Makino I Tohoku J Exp Med; 1990 Apr; 160(4):301-9. PubMed ID: 2382259 [TBL] [Abstract][Full Text] [Related]
9. Immunochemical methods for quantification of human apolipoprotein C-III. Kashyap ML Methods Enzymol; 1996; 263():208-18. PubMed ID: 8749009 [No Abstract] [Full Text] [Related]
10. Rapid assessment of the distribution of apolipoproteins C-II and C-III subspecies in triglyceride-rich lipoproteins by isoelectric focusing. Bugugnani MJ; Koffigan M; Kora I; Ouvry D; Clavey V; Fruchart JC Clin Chem; 1984 Mar; 30(3):349-51. PubMed ID: 6697477 [TBL] [Abstract][Full Text] [Related]
11. Alterations of lipids and apolipoprotein CIII in very low density lipoprotein subspecies in type 2 diabetes. Hiukka A; Fruchart-Najib J; Leinonen E; Hilden H; Fruchart JC; Taskinen MR Diabetologia; 2005 Jun; 48(6):1207-15. PubMed ID: 15864534 [TBL] [Abstract][Full Text] [Related]
12. [Apolipoproteins AI, B100, CII, CIII and E in human cerebrospinal fluid]. Liu Y; Liu B; Yin J; Wu K; Wu L Hua Xi Yi Ke Da Xue Xue Bao; 1991 Sep; 22(4):352-4. PubMed ID: 1814810 [TBL] [Abstract][Full Text] [Related]
13. Presence of Apo B48, and relative Apo CII deficiency and Apo CIII enrichment in uremic very-low density lipoproteins. Atger V; Beyne P; Frommherz K; Roullet JB; Drüeke T Ann Biol Clin (Paris); 1989; 47(8):497-501. PubMed ID: 2690681 [TBL] [Abstract][Full Text] [Related]
14. Effect of human high density lipoproteins, anti-apolipoproteins CII and CIII, and hydrolysis of very low density lipoprotein (VLDL) cholesterol ester on VLDL catabolism in vitro. Liu BW; Hynd BA; Kashyap ML Biochem Biophys Res Commun; 1984 Jun; 121(3):946-52. PubMed ID: 6588972 [TBL] [Abstract][Full Text] [Related]
15. A simplified and efficient procedure for the purification of apolipoprotein AI from human serum high-density lipoprotein-3 by preparative isoelectric focussing on polyacrylamide gel beads. Forgez P; Chapman MJ J Biochem Biophys Methods; 1982 Sep; 6(4):283-96. PubMed ID: 6183309 [TBL] [Abstract][Full Text] [Related]
16. Abnormal concentrations of CII, CIII, and E apolipoproteins among apolipoprotein B-containing, B-free, and A-I-containing lipoprotein particles in hemodialysis patients. Alsayed N; Rebourcet R Clin Chem; 1991 Mar; 37(3):387-93. PubMed ID: 2004445 [TBL] [Abstract][Full Text] [Related]
17. Apolipoprotein B metabolism in subjects with deficiency of apolipoproteins CIII and AI. Evidence that apolipoprotein CIII inhibits catabolism of triglyceride-rich lipoproteins by lipoprotein lipase in vivo. Ginsberg HN; Le NA; Goldberg IJ; Gibson JC; Rubinstein A; Wang-Iverson P; Norum R; Brown WV J Clin Invest; 1986 Nov; 78(5):1287-95. PubMed ID: 3095375 [TBL] [Abstract][Full Text] [Related]
18. Apo CIII Proteoforms, Plasma Lipids, and Cardiovascular Risk in MESA. Sinari S; Koska J; Hu Y; Furtado J; Jensen MK; Budoff MJ; Nedelkov D; McClelland RL; Billheimer D; Reaven P Arterioscler Thromb Vasc Biol; 2023 Aug; 43(8):1560-1571. PubMed ID: 37317850 [TBL] [Abstract][Full Text] [Related]
19. Concentrations of apoprotein CII, CIII, and E in total serum and in the apoprotein B-containing lipoproteins, determined by a new enzyme-linked immunosorbent assay. Alsayed N; Rebourcet R; Chapman J Clin Chem; 1990 Dec; 36(12):2047-52. PubMed ID: 2253344 [TBL] [Abstract][Full Text] [Related]
20. Analytical isoelectric focusing of apolipoprotein B of human plasma low-density lipoproteins in the presence of a nonionic and a zwitterionic detergent. Melnik BC; Melnik SF Anal Biochem; 1988 Jun; 171(2):320-9. PubMed ID: 3407929 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]